+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Antiphospholipid Syndrome (APS) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Antiphospholipid Syndrome (APS) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 79 Pages
  • Global
From
Chronic Heart Failure - Epidemiology Forecast - 2034 - Product Thumbnail Image

Chronic Heart Failure - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 165 Pages
  • Global
From
Helicobacter Pylori Infections - Epidemiology Forecast - 2034 - Product Thumbnail Image

Helicobacter Pylori Infections - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 90 Pages
  • Global
From
From
Cocaine Intoxication - Epidemiology Forecast - 2034 - Product Thumbnail Image

Cocaine Intoxication - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 47 Pages
  • Global
From
Opioid Withdrawal Syndrome - Epidemiology Forecast - 2034 - Product Thumbnail Image

Opioid Withdrawal Syndrome - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 84 Pages
  • Global
From
From
Idiopathic Membranous Nephropathy - Epidemiology Forecast - 2034 - Product Thumbnail Image

Idiopathic Membranous Nephropathy - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 69 Pages
  • Global
From
Myotonic Dystrophy - Epidemiology Forecast - 2034 - Product Thumbnail Image

Myotonic Dystrophy - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 105 Pages
  • Global
From
Parainfluenza Virus Infection - Epidemiology Forecast - 2034 - Product Thumbnail Image

Parainfluenza Virus Infection - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 60 Pages
  • Global
From
Prader-Willi Syndrome - Epidemiology Forecast - 2034 - Product Thumbnail Image

Prader-Willi Syndrome - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 80 Pages
  • Global
From
Stargardt Disease (STGD) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Stargardt Disease (STGD) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 66 Pages
  • Global
From
Obstructive Sleep Apnea (OSA) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Obstructive Sleep Apnea (OSA) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 75 Pages
  • Global
From
From
Mild Cognitive Impairment - Epidemiology Forecast - 2034 - Product Thumbnail Image

Mild Cognitive Impairment - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 106 Pages
  • Global
From
Diabetic Kidney Disease (DKD) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Diabetic Kidney Disease (DKD) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 95 Pages
  • Global
From
Epidermolysis Bullosa - Epidemiology Forecast - 2034 - Product Thumbnail Image

Epidermolysis Bullosa - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 91 Pages
  • Global
From
Sickle Cell Disease - Epidemiology Forecast - 2034 - Product Thumbnail Image

Sickle Cell Disease - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 99 Pages
  • Global
From
Acute Kidney Injury (AKI) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Acute Kidney Injury (AKI) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 90 Pages
  • Global
From
Amyotrophic Lateral Sclerosis (ALS) - Epidemiology Forecast - 2034 - Product Thumbnail Image

Amyotrophic Lateral Sclerosis (ALS) - Epidemiology Forecast - 2034

  • Report
  • December 2024
  • 133 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more